Denosumab Global Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases

Trial Profile

Denosumab Global Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Jun 2017

At a glance

  • Drugs Denosumab (Primary) ; Osteoporosis therapies
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions
  • Sponsors Amgen
  • Most Recent Events

    • 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 14 Aug 2011 Trial details updated from abstract presented at 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
    • 11 Jan 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top